![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 31, 2012 11:10:34 PM
Session details.
NSCLC - Immunotherapy, SCLC and Mesothelioma
Moderators: M. O'Brien, Dr., J.F. Vansteenkiste, Dr
Session Info: Poster Discussion, [] NSCLC - Immunotherapy, SCLC and Mesothelioma
Day/Date: Saturday, September 29, 2012
Session Time: 12:40 PM - 2:00 PM
1237PD | Clinical activity and safety of anti-programmed death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
S. Gettinger1, L. Horn2, S.J. Antonia3, D.R. Spigel2, L. Gandhi4, L.V. Sequist4, J.M. Wigginton5, G. Kollia5, A. Gupta5, J.R. Brahmer6
1New Haven, CT/US, 2Nashville, TN/US, 3Tampa, FL/US, 4Boston, MA/US, 5Princeton, NJ/US, 6Baltimore, MD/US
1238PD | Active Specific Immunotherapy with Racotumomab in the Treatment of Advanced Non Small Cell Lung Cancer (NSCLC).
A. Macías1, S. Alfonso2, E. Santiesteban3, C. Viada1, I. Mendoza1, P.P. Guerra1, R.E. Gómez4, M.L. Ardigo4, A.M. Vázquez1, R. Pérez1
1Havana/CU, 2Las Villas/CU, 3Matanzas/CU, 4Buenos Aires/AR
LBA35 | Randomized, double-blind, placebo (P)-controlled phase 2 trial of Bavituximab (B) plus Docetaxel (D) in patients with previously treated locally advanced or metastatic non-squamous non-small-cell lung cancer
D.E. Gerber1, M. Joppert2, D.R. Spigel3, D. Singh4, D. Giorgadze5, M. Shtivelband6, O. Ponomarova7, J. Shan8, C.P. Belani9
1Dallas, TX/US, 2Ft. Meyers, FL/US, 3Nashville, TN/US, 4Jaipur/IN, 5Tbilisi/GE, 6Chandler, AZ/US, 7Kiev/UA, 8Tustin, CA/US, 9Hershey, PA/US
[12:40 PM] Invited Discussant, Abstracts 1237PD, 1238PD and LBA35
Speaker: J.F. Vansteenkiste
Leuven/BE
----------------------------------------------------------------------------------------------------
J.F. Vansteenkiste, MD, PhD
Respiratory Oncology Unit (Pulmonology) University Hospital Gasthuisberg, Leuven, Belgium
Here is a discussion he did at the ESMO meeting in 2010 of 5 posters.
https://www.webges.com/cslide/library/esmo/mylibrary/search/author/0/J.%20F.%20Vansteenkiste
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM